Posts by: Kara Elam

Kara Elam

August 18, 2016August 18, 2016

Lilly’s Phase 3 Trial for Advanced Breast Cancer Therapy to Continue Following Review by Data Monitoring Committee

News

Eli Lilly will continue its MONARCH 2 Phase 3 clinical trial of abemaciclib for advanced breast cancer into the first half of 2017, including a final analysis of patients’ progression-free survival rate, ... Read more

August 2, 2016August 2, 2016

Novel Peptide Found to Kill Breast Cancer, Leave Healthy Tissue Unharmed

News

A newly found peptide that can kill tumor cells while sparing healthy cells could be an effective therapeutic strategy, when combined with other drugs, for drug-resistant cancers such as breast cancer, according ... Read more

June 13, 2016June 13, 2016

Radiopharmaceuticals and Breast Cancer

News

Radiopharmaceuticals Radiopharmaceuticals are a group of radioactive compounds that are used in medicine to either diagnose or treat disease. These compounds contain radioactive materials called radioisotopes. They are given either intravenously (IV), orally, ... Read more

June 9, 2016June 9, 2016

Exemestane and Everolimus: Hormone and Biological Therapy Treatment Combination

News

Exemestane Exemestane, also known as Aromasin, is a type of oral, targeted cancer therapy called an aromatase inhibitor and works by a mechanism that stops the production of estrogen in ... Read more

May 24, 2016May 24, 2016

Researchers Discover a Triple-Negative Breast Cancer Target

Breast Cancer News, News

University of California researchers have published findings in the journal Cell Chemical Biology that may lead to the development of novel breast cancer treatments that successfully target and eliminate triple-negative breast tumors (TNBT). ... Read more

April 27, 2016April 27, 2016

Combination Therapy Seen to Slow Further Spread of Metastatic Breast Cancer in Clinical Trial

News

In women with ERBB2-positive metastatic breast cancer, the combination treatment of neratinib-paclitaxel may help to delay and reduce metastases in the central nervous system compared to trastuzumab-paclitaxel. The study, “Neratinib Plus ... Read more

April 6, 2015April 6, 2015

Targeting Cellular Quality Control Mechanisms Increases Efficacy of Breast Cancer Chemotherapy Drug

Breast Cancer News, News

Researchers from the University of Rochester Medical Center (URMC) in Rochester, NY recently released the results of a study that provides evidence of a treatment strategy that could increase the ... Read more

February 24, 2015October 18, 2016

Researchers Discover Important Genetic Variant Linked to Breast Cancer Risk

News

A study published in the latest edition of the journal Human Molecular Genetics used fine-mapping analysis of genetic data to assess the association between individual genetic variations among patients and ... Read more